SEC Form 4 · accession 0000899243-16-023362
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric S Lander
Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 17, 2016 | A | 6,578 | $1.52 | A | 80,319 | D | |
| Common StockF2 | holding | — | — | — | 11,051 | I | Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.52 | Jun 17, 2016 | A | 20,000 | A | — | Jun 17, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of approximately one-quarter of such person's $40,000 annual retainer for service as a director.
- F2These shares are held by the Lander-Weiner Family Trust. Dr. Lander disclaims beneficial ownership of the shares held by the Lander-Weiner Family Trust except to the extent of any pecuniary interest therein.
- F3The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
Remarks
Ex. 24: Limited Power of Attorney